Question 1

Purpose of the Screening

Accepted Answer

Ensuring thyroid safety and excluding medullary thyroid cancer. Evaluating pancreatic function to ensure no underlying inflammation. Providing a medical baseline for comparison after starting therapy.

Question 2

Why is this Screening Necessary?

Accepted Answer

GLP-1 medications are linked to a slight risk of pancreatitis. These drugs are contraindicated for those with a family history of Medullary Thyroid Carcinoma. Pre-clearance reduces anxiety regarding potential side effects.

Question 3

Target Groups

Accepted Answer

Individuals planning to start weight-loss injections (Ozempic, Saxenda, Mounjaro). Diabetic patients transitioning to GLP-1 receptor agonists. Individuals with risk factors related to the pancreas or thyroid gland.

Start Your Weight-Loss Journey Safely - Pre-GLP-1 Agonist Hormonal and Enzyme Screening